AroCell AB (Sweden) Today
| AROC Stock | SEK 0.40 0.01 2.44% |
Performance0 of 100
| Odds Of DistressLess than 46
|
AroCell AB is selling for under 0.4 as of the 26th of November 2024; that is 2.44 percent decrease since the beginning of the trading day. The stock's last reported lowest price was 0.39. AroCell AB has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. Equity ratings for AroCell AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 27th of September 2024 and ending today, the 26th of November 2024. Click here to learn more.
AroCell AB , a vitro diagnostics company, focuses on the monitoring of hematological malignancies, breast cancer, and other solid tumors. AroCell AB was founded in 2003 and is based in Uppsala, Sweden. AroCell AB is traded on Stockholm Stock Exchange in Sweden. The company has 230.36 M outstanding shares. More on AroCell AB
Moving together with AroCell Stock
Moving against AroCell Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
AroCell Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AroCell AB's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AroCell AB or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Health Care, Life Sciences Tools & Services, Drug Manufacturers - Major, Healthcare (View all Sectors) |
AroCell AB (AROC) is traded on Stockholm Exchange in Sweden and employs 20 people. The company currently falls under 'Small-Cap' category with a current market capitalization of 152.77 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AroCell AB's market, we take the total number of its shares issued and multiply it by AroCell AB's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AroCell AB operates under Life Sciences Tools & Services sector and is part of Health Care industry. The entity has 230.36 M outstanding shares.
AroCell AB has accumulated about 21.43 M in cash with (28.21 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.52, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check AroCell AB Probability Of Bankruptcy
Ownership AllocationAroCell AB holds a total of 230.36 Million outstanding shares. AroCell AB retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check AroCell Ownership Details
AroCell AB Risk Profiles
Although AroCell AB's alpha and beta are two of the key measurements used to evaluate AroCell AB's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.14 | |||
| Standard Deviation | 2.91 | |||
| Variance | 8.44 | |||
| Risk Adjusted Performance | (0.15) |
AroCell Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in AroCell AB without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
AroCell AB Corporate Management
Elected by the shareholders, the AroCell AB's board of directors comprises two types of representatives: AroCell AB inside directors who are chosen from within the company, and outside directors, selected externally and held independent of AroCell. The board's role is to monitor AroCell AB's management team and ensure that shareholders' interests are well served. AroCell AB's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, AroCell AB's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Gustav Sten | Chief Officer | Profile | |
| BSc BSc | Chief Officer | Profile | |
| Tina Yang | Chief Officer | Profile | |
| Marie Torstensson | Chief Officer | Profile | |
| Gunnar Wahlberg | Chief Rapid | Profile | |
| Maria Olofsson | Chief Officer | Profile | |
| Ellen Dittberner | Chief Officer | Profile |
Additional Tools for AroCell Stock Analysis
When running AroCell AB's price analysis, check to measure AroCell AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AroCell AB is operating at the current time. Most of AroCell AB's value examination focuses on studying past and present price action to predict the probability of AroCell AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AroCell AB's price. Additionally, you may evaluate how the addition of AroCell AB to your portfolios can decrease your overall portfolio volatility.